1. Associations between biomarker status (amyloid, tau) and risk for progression to MCI/Dementia in the Harvard Aging Brain Study. (1st February 2022) Authors: Papp, Kate V.; Rentz, Dorene M.; Winskill, Carolyn; Betensky, Rebecca A.; Amariglio, Rebecca E.; Schultz, Aaron P.; Johnson, Keith A.; Sperling, Reisa A. Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 4 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Associations between biomarker status (amyloid, tau) and risk for progression to MCI/Dementia in the Harvard Aging Brain Study. (December 2021) Authors: Papp, Kate V.; Rentz, Dorene M.; Winskill, Carolyn; Betensky, Rebecca A.; Amariglio, Rebecca E.; Schultz, Aaron P.; Johnson, Keith A.; Sperling, Reisa A. Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 4 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of Anti‐VEGF Therapy on the Disease Progression of Neovascular Age‐Related Macular Degeneration: A Systematic Review and Model‐Based Meta‐Analysis. (5th January 2022) Authors: Luu, Kenneth T.; Seal, Jennifer; Green, Michelle; Winskill, Carolyn; Attar, Mayssa Journal: Journal of clinical pharmacology Issue: Volume 62:Number 5(2022) Page Start: 594 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗